Target intelligence / Profile preview

DPP3 pseudogene 1 (DPP3P1)

Target
DPP3P1
Molecular classification
Other (Pseudogene)
01

Overview

DPP3 pseudogene 1 (DPP3P1) is a non-protein-coding pseudogene related to the dipeptidyl-peptidase 3 gene. As a pseudogene, it does not encode an active enzyme or functional receptor and is not known to play a role in human disease, act as a biomarker, or serve as a drug target. Pseudogenes are typically considered genomic relics without biological activity, although in rare cases they can have regulatory functions. However, current sources do not indicate known biological or clinical significance for DPP3P1.

Other names
DPP3P1DPP3 pseudogene 1

Beyond the preview

Go deeper on DPP3 pseudogene 1 (DPP3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DPP3 pseudogene 1 (DPP3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call